Haemonetics Corp.
NYSE:HAE
| Market Cap (Intraday) | 4.13B |
| Current PE | 32.60 |
| Forward PE | 20.52 |
| 2yr Forward PE | 18.46 |
| 10-Day MA | $83.98 |
| 50-Day MA | $78.86 |
| 200-Day MA | $84.81 |
Haemonetics Corp. Stock, NYSE:HAE
125 Summer Street, Boston, Massachusetts 02110
United States of America
Phone: +1.781.848.7100
Number of Employees: 3034
Description
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, Hospital, and Corporate. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.